《公司業績》翠華控股(01314.HK)中期盈轉虧蝕4,450萬元 不派中期息
翠華控股(01314.HK)公布9月底止中期業績,錄得4,450.2萬元虧損,去年同期則錄得1,447.1萬元盈利。每股虧損3.15仙。不派息,去年同期則派中期息1仙。
期內錄得8.38億元收入,按年倒退6.4%。其中本港收入倒退4.5%至5.37億元,中國收入倒退10.2%至2.92億元。另外合營企業銷售食品收入則按年增長8.1%至917.5萬元。毛利按年跌7.6%至5.97億元,毛利率由72.1%降至71.2%。
至9月底止,公司於香港有41間餐廳,中國有38間,兩地較去年同期分別增加5間及4間。澳門餐廳數目則維持3間,新加坡餐廳數目2間,較去年同期增加1間。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.